Related Experiment Video

Updated: Jun 5, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

Developmental pharmacokinetics

Gail D Anderson1

  • 1Department of Pharmacy, University of Washington, Seattle, WA98195, USA. gaila@u.washington.edu

Seminars in Pediatric Neurology
|December 25, 2010
PubMed

Insights

Pediatric drug dosing differs from adults due to physiological changes affecting drug processing. Weight-adjusted doses vary based on a child's age and how the drug is metabolized or excreted.

Area of Science:

  • Pharmacology
  • Pediatrics
  • Drug Metabolism

Background:

  • Physiological maturation leads to age-specific differences in pharmacokinetics and drug response.
  • Pediatric populations exhibit unique pharmacokinetic profiles compared to adults, influencing drug efficacy and safety.

Purpose of the Study:

  • To analyze age-related pharmacokinetic variations in children.
  • To guide appropriate pediatric drug dosing strategies based on developmental changes.

Main Methods:

  • Review of pharmacokinetic data across different pediatric age groups.
  • Comparison of drug elimination pathways (e.g., CYP enzymes, renal excretion) in children versus adults.

Main Results:

  • Neonates and infants require lower weight-adjusted doses due to reduced protein binding, renal excretion, and metabolism.
  • Children over one year may need higher weight-corrected doses for drugs metabolized by CYP1A2, CYP2C9, and CYP3A4.
  • Dosing is similar to adults for drugs cleared by renal excretion or specific metabolic pathways (CYP2C19, CYP2D6, NAT, UGT).

Conclusions:

  • Understanding age-related pharmacokinetic changes is crucial for safe and effective pediatric drug use.
  • Limited data for many pediatric drugs necessitates careful consideration of pharmacokinetic principles for dosing.
  • Pharmacokinetic insights can inform dosing decisions in the absence of specific pediatric drug approval and data.

More Related Videos

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetic–Pharmacodynamic Relationship: Model Components01:14

Pharmacokinetic–Pharmacodynamic Relationship: Model Components

Pharmacokinetic-pharmacodynamic (PK–PD) modeling is essential in drug development and clinical pharmacology. It provides a quantitative framework to predict drug behavior and response over time. This approach integrates pharmacokinetics (PK), which describes the drug's absorption, distribution, metabolism, and excretion, with pharmacodynamics (PD), which characterizes the drug’s biological effects and mechanisms of action.The disposition kinetics of a drug determine its plasma...
Chronopharmacokinetics: Time-Dependent Pharmacokinetics01:20

Chronopharmacokinetics: Time-Dependent Pharmacokinetics

Chronopharmacokinetics studies the temporal change in drug absorption and elimination. These changes can be cyclical or non-cyclical. Cyclical changes occur over a regular interval, while non-cyclical changes occur over a longer, irregular period.
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...